Wells Fargo & Company SAREPTA THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
2,297,000
Previous 7,876,000 70.84%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-5,579,000 Reduced 70.84%
2,297,000 $0
Q1 2025

May 13, 2025
BUY
N/A
6,503,000 Added 473.63%
7,876,000 $0
Q4 2024

Feb 12, 2025
SELL
N/A
-55,000 Reduced 3.85%
1,373,000 $0
Q3 2024

Nov 13, 2024
SELL
N/A
-8,133,000 Reduced 85.06%
1,428,000 $0
Q2 2024

Aug 13, 2024
BUY
N/A
6,249,000 Added 188.68%
9,561,000 $0
Q1 2024

May 10, 2024
BUY
N/A
2,437,000 Added 278.51%
3,312,000 $0
Q4 2023

Feb 09, 2024
BUY
N/A
420,000 Added 92.31%
875,000 $0
Q3 2023

Nov 13, 2023
BUY
N/A
455,000 New
455,000 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email